FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014328508> ?p ?o ?g. }

• W3014328508 endingPage "2025" @default.
• W3014328508 startingPage "2009" @default.
• W3014328508 abstract "Abstract The two fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine (4F-Cy-BAP) and furanoyl-1-benzyl-4-anilinopiperidine (Fu-BAP) have recently been seized as new psychoactive substances (NPS) on the drugs of abuse market. As their toxicokinetic and toxicodynamic characteristics are completely unknown, this study focused on elucidating their in vitro metabolic stability in pooled human liver S9 fraction (pHLS9), their qualitative in vitro (pHLS9), and in vivo (zebrafish larvae) metabolism, and their in vitro isozyme mapping using recombinant expressed isoenzymes. Their maximum-tolerated concentration (MTC) in zebrafish larvae was studied from 0.01 to 100 µM. Their µ-opioid receptor (MOR) activity was analyzed in engineered human embryonic kidney (HEK) 293 T cells. In total, seven phase I and one phase II metabolites of 4F-Cy-BAP and 15 phase I and four phase II metabolites of Fu-BAP were tentatively identified by means of liquid chromatography high-resolution tandem mass spectrometry, with the majority detected in zebrafish larvae. N -Dealkylation, N -deacylation, hydroxylation, and N -oxidation were the most abundant metabolic reactions and the corresponding metabolites are expected to be promising analytical targets for toxicological analysis. Isozyme mapping revealed the main involvement of CYP3A4 in the phase I metabolism of 4F-Cy-BAP and in terms of Fu-BAP additionally CYP2D6. Therefore, drug-drug interactions by CYP3A4 inhibition may cause elevated drug levels and unwanted adverse effects. MTC experiments revealed malformations and changes in the behavior of larvae after exposure to 100 µM Fu-BAP. Both substances were only able to produce a weak activation of MOR and although toxic effects based on MOR activation seem unlikely, activity at other receptors cannot be excluded." @default.
• W3014328508 created "2020-04-10" @default.
• W3014328508 creator A5005967499 @default.
• W3014328508 creator A5006156563 @default.
• W3014328508 creator A5006906194 @default.
• W3014328508 creator A5023065580 @default.
• W3014328508 creator A5031749726 @default.
• W3014328508 creator A5077818118 @default.
• W3014328508 creator A5080065303 @default.
• W3014328508 creator A5085526664 @default.
• W3014328508 creator A5087166832 @default.
• W3014328508 creator A5089838749 @default.
• W3014328508 date "2020-04-05" @default.
• W3014328508 modified "2023-09-26" @default.
• W3014328508 title "Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine" @default.
• W3014328508 cites W1175366871 @default.
• W3014328508 cites W152943885 @default.
• W3014328508 cites W1974290383 @default.
• W3014328508 cites W1978154072 @default.
• W3014328508 cites W1985396940 @default.
• W3014328508 cites W2013381750 @default.
• W3014328508 cites W2016812290 @default.
• W3014328508 cites W2039719637 @default.
• W3014328508 cites W2040426460 @default.
• W3014328508 cites W2076178279 @default.
• W3014328508 cites W2114816473 @default.
• W3014328508 cites W2118630726 @default.
• W3014328508 cites W2132047249 @default.
• W3014328508 cites W2132344933 @default.
• W3014328508 cites W2178723555 @default.
• W3014328508 cites W2209408218 @default.
• W3014328508 cites W2265096866 @default.
• W3014328508 cites W2423462655 @default.
• W3014328508 cites W2514902469 @default.
• W3014328508 cites W2577581107 @default.
• W3014328508 cites W2601256495 @default.
• W3014328508 cites W2742295098 @default.
• W3014328508 cites W2744928464 @default.
• W3014328508 cites W2768922681 @default.
• W3014328508 cites W2786430007 @default.
• W3014328508 cites W2804132168 @default.
• W3014328508 cites W2805383067 @default.
• W3014328508 cites W2806616881 @default.
• W3014328508 cites W2890437006 @default.
• W3014328508 cites W2901741795 @default.
• W3014328508 cites W2902661944 @default.
• W3014328508 cites W2914878453 @default.
• W3014328508 cites W2915919849 @default.
• W3014328508 cites W2930584951 @default.
• W3014328508 cites W2955414598 @default.
• W3014328508 cites W2969855370 @default.
• W3014328508 cites W2971089892 @default.
• W3014328508 cites W2978137052 @default.
• W3014328508 cites W2994292607 @default.
• W3014328508 cites W2995047685 @default.
• W3014328508 cites W4211163004 @default.
• W3014328508 doi "https://doi.org/10.1007/s00204-020-02726-1" @default.
• W3014328508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7303074" @default.
• W3014328508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32249346" @default.
• W3014328508 hasPublicationYear "2020" @default.
• W3014328508 type Work @default.
• W3014328508 sameAs 3014328508 @default.
• W3014328508 citedByCount "18" @default.
• W3014328508 countsByYear W30143285082020 @default.
• W3014328508 countsByYear W30143285082021 @default.
• W3014328508 countsByYear W30143285082022 @default.
• W3014328508 countsByYear W30143285082023 @default.
• W3014328508 crossrefType "journal-article" @default.
• W3014328508 hasAuthorship W3014328508A5005967499 @default.
• W3014328508 hasAuthorship W3014328508A5006156563 @default.
• W3014328508 hasAuthorship W3014328508A5006906194 @default.
• W3014328508 hasAuthorship W3014328508A5023065580 @default.
• W3014328508 hasAuthorship W3014328508A5031749726 @default.
• W3014328508 hasAuthorship W3014328508A5077818118 @default.
• W3014328508 hasAuthorship W3014328508A5080065303 @default.
• W3014328508 hasAuthorship W3014328508A5085526664 @default.
• W3014328508 hasAuthorship W3014328508A5087166832 @default.
• W3014328508 hasAuthorship W3014328508A5089838749 @default.
• W3014328508 hasBestOaLocation W30143285081 @default.
• W3014328508 hasConcept C109650736 @default.
• W3014328508 hasConcept C119795356 @default.
• W3014328508 hasConcept C150903083 @default.
• W3014328508 hasConcept C181199279 @default.
• W3014328508 hasConcept C185592680 @default.
• W3014328508 hasConcept C195289149 @default.
• W3014328508 hasConcept C19749203 @default.
• W3014328508 hasConcept C207001950 @default.
• W3014328508 hasConcept C2781109383 @default.
• W3014328508 hasConcept C526171541 @default.
• W3014328508 hasConcept C55493867 @default.
• W3014328508 hasConcept C62231903 @default.
• W3014328508 hasConcept C86803240 @default.
• W3014328508 hasConcept C89311334 @default.
• W3014328508 hasConcept C98274493 @default.
• W3014328508 hasConceptScore W3014328508C109650736 @default.
• W3014328508 hasConceptScore W3014328508C119795356 @default.
• W3014328508 hasConceptScore W3014328508C150903083 @default.
• W3014328508 hasConceptScore W3014328508C181199279 @default.

• next